NIH-funded research R01 grant

Fructose and liver health in obesity: how gut sugar handles affect NAFLD risk

Official title: Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity

Funded at Touro University of California · NIH-11392419 · Data updated 2026-11-12

A study in adults with and without obesity will explore how fructose is processed in the body and how that processing may protect or harm the liver.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTouro University of California
NIH-funded
Lab location1 site (Vallejo, United States)
Project startAugust 13, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$730,498
NIH project number5R01DK140477-02
Project IDNIH-11392419 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21+, with and without obesity, who can follow defined dietary protocols and provide consent for dietary testing.

Less likely to help

Individuals who cannot participate in dietary challenge sessions or have other health conditions preventing participation may not benefit.

What this research studies

Researchers will examine how fructose is converted to glucose in the intestine and how this might shield the liver from fat buildup, comparing people with obesity to those without. The study uses one-day dietary sessions to measure liver-related responses and fat synthesis after controlled fructose intake. By focusing on real people and dietary patterns, the project aims to clarify why fructose may affect liver health differently depending on obesity status. Results could inform personalized dietary guidance for preventing type 2 diabetes and NAFLD.

Why it matters

Potential benefit: If successful, the findings could lead to more tailored dietary recommendations to reduce liver fat and diabetes risk in people with obesity.

How similar studies have gone: Previous work links fructose to liver fat formation, but this study tests a specific intestinal glucose conversion mechanism and its variation by obesity.

Where this research is happening

  • Touro University of California
    Vallejo, United States
    Active

Researchers

  • Principal investigator: Schwarz, Jean-Marc — Touro University of California
  • Study coordinator: Schwarz, Jean-Marc

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.